{"cord_uid":"rbye73yv", "sourcedb":"PMC", "sourceid":"PMC6567157", "divid":21, "text":"Although monoclonal antibodies show promising antiviral effects in both cell culture and animal models against MERS-CoV infection, their roles are still limited in large-scale disease prevention in MERS-CoV high risk areas, as the therapeutic window is generally narrow for mAbs and mass-scale production is timeand resource-consuming. Vaccines still remain the best choice for MERS-CoV prevention.", "project":"cdlai_CORD-19", "denotations":[]}